Product Information
QC COLD-FLU SEVERE CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.1372 per EA under NDC 83324011124. Its NADAC has been published 82 times since Dec 4, 2024.
QC COLD-FLU SEVERE CAPLET
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324011124
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/18/2024
Pharmacological Classes
Price Statistics
The NADAC for QC COLD-FLU SEVERE CAPLET has been published 82 times since Dec 4, 2024, and over the history we have for it it has risen 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1372 per EA |
|---|---|
| All-time high | $0.1429 (Jun 11, 2025) |
| All-time low | $0.1267 (Oct 22, 2025) |
| 52-week high | $0.1408 |
| 52-week low | $0.1267 |
| Median price | $0.1317 |
| Average price | $0.1331 |
| Largest weekly change | +5.5% (Mar 18, 2026) |
| Weeks tracked | 82 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC COLD-FLU SEVERE CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC COLD-FLU SEVERE CAPLET, manufactured by Chain Drug Marketing Association, is $0.1372 per EA (NDC 83324011124), effective Jun 24, 2026.
How has the price of QC COLD-FLU SEVERE CAPLET changed over time?
Over the history we have for it, the NADAC for QC COLD-FLU SEVERE CAPLET has risen 5.8%. It has been tracked across 82 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC COLD-FLU SEVERE CAPLET?
Since Dec 4, 2024, the NADAC for QC COLD-FLU SEVERE CAPLET has ranged from a low of $0.1267 (Oct 22, 2025) to a high of $0.1429 (Jun 11, 2025), with a median of $0.1317 per EA.
Are there cheaper alternatives to QC COLD-FLU SEVERE CAPLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as QC COLD-FLU SEVERE CAPLET, but none are currently priced below it.
Who manufactures QC COLD-FLU SEVERE CAPLET?
QC COLD-FLU SEVERE CAPLET (NDC 83324011124) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification